Bao Phung

1.4k total citations
8 papers, 38 citations indexed

About

Bao Phung is a scholar working on Infectious Diseases, Virology and Sociology and Political Science. According to data from OpenAlex, Bao Phung has authored 8 papers receiving a total of 38 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 2 papers in Virology and 2 papers in Sociology and Political Science. Recurrent topics in Bao Phung's work include HIV/AIDS Research and Interventions (3 papers), HIV/AIDS drug development and treatment (3 papers) and HIV Research and Treatment (2 papers). Bao Phung is often cited by papers focused on HIV/AIDS Research and Interventions (3 papers), HIV/AIDS drug development and treatment (3 papers) and HIV Research and Treatment (2 papers). Bao Phung collaborates with scholars based in France, Morocco and Mali. Bao Phung's co-authors include Yazdan Yazdanpanah, V. Descamps, Roland Landman, F. Bouscarat, Lise Larcher, Hedi Mammeri, Sylvie Le Gac, Diane Descamps, Valentina Isernia and Antoine Bachelard and has published in prestigious journals such as PLoS ONE, Emerging infectious diseases and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Bao Phung

7 papers receiving 37 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bao Phung France	4	25	12	11	10	4	8	38
Michael Semwogerere United States	4	18 0.7×	13 1.1×	6 0.5×	11 1.1×	3 0.8×	5	42
Francis Kiweewa United States	5	39 1.6×	13 1.1×	35 3.2×	13 1.3×	3 0.8×	9	75
Nitesha Jeenarain South Africa	4	27 1.1×	13 1.1×	13 1.2×	19 1.9×	3 0.8×	9	36
Stefanie Sammet Germany	5	19 0.8×	5 0.4×	5 0.5×	22 2.2×	3 0.8×	14	43
Doug Grove United States	4	24 1.0×	6 0.5×	4 0.4×	17 1.7×	5 1.3×	5	33
Federica Faggian Italy	4	23 0.9×	7 0.6×	6 0.5×	14 1.4×		10	40
A.I. van Sighem Netherlands	3	25 1.0×	5 0.4×	9 0.8×	30 3.0×	6 1.5×	3	43
Mary-Grace Brandt United States	3	13 0.5×	18 1.5×	11 1.0×	18 1.8×	2 0.5×	4	38
Eline LM Op de Coul Netherlands	4	19 0.8×	5 0.4×	20 1.8×	18 1.8×	1 0.3×	5	31
Vicente Descalzo Spain	5	14 0.6×	4 0.3×	12 1.1×	24 2.4×		8	45

Countries citing papers authored by Bao Phung

Since Specialization

Citations

This map shows the geographic impact of Bao Phung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bao Phung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bao Phung more than expected).

Fields of papers citing papers by Bao Phung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bao Phung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bao Phung. The network helps show where Bao Phung may publish in the future.

Co-authorship network of co-authors of Bao Phung

This figure shows the co-authorship network connecting the top 25 collaborators of Bao Phung. A scholar is included among the top collaborators of Bao Phung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bao Phung. Bao Phung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Lê, Minh, Clotilde Allavena, Véronique Joly, et al.. (2025). Switch to bictegravir/emtricitabine/tenofovir alafenamide in people living with HIV aged 65 years or older: BICOLDER study – IMEA 057. Journal of Infection and Public Health. 18(11). 102946–102946.

Siguier, Martin, Olivier Robineau, M. Valette, et al.. (2024). Incidence and factors associated with PrEP discontinuation in France. Journal of Antimicrobial Chemotherapy. 79(7). 1555–1563. 2 indexed citations

Bachelard, Antoine, Aurélie Sautereau, Valentina Isernia, et al.. (2022). Risk Factors Associated with Severe/Critical COVID-19 in People Living with HIV-1. International Journal of Infectious Diseases. 122. 152–154. 8 indexed citations

Isernia, Valentina, Bao Phung, A. Leprêtre, et al.. (2020). Pre-exposure HIV prophylaxis (PrEP) among transgender women: 3 years of follow-up in a university hospital in Paris. Sexually Transmitted Infections. 97(6). 465–466. 3 indexed citations

Mammeri, Hedi, Lise Larcher, V. Descamps, et al.. (2018). Orogenital Transmission of Neisseria meningitidis Causing Acute Urethritis in Men Who Have Sex with Men. Emerging infectious diseases. 25(1). 175–176. 12 indexed citations

Charpentier, Charlotte, Gilles Peytavin, Minh Lê, et al.. (2018). High virological suppression regardless of the genotypic susceptibility score after switching to a dolutegravir-based regimen: week 48 results in an observational cohort. Journal of Antimicrobial Chemotherapy. 73(6). 1665–1671. 9 indexed citations

Charpentier, Charlotte, Minh Lê, Véronique Joly, et al.. (2015). Use of PCR Signal and Therapeutic Drug Monitoring in a Switch Cohort Study to Tenofovir/Emtricitabine/Rilpivirine: A W96 Follow-Up. PLoS ONE. 10(7). e0134430–e0134430. 3 indexed citations

Bouscarat, F., E. Bouvet, E. Maubec, et al.. (2015). Infection à VIH, infections sexuellement transmises et complications dermatologiques chez les sujets transgenres consultant en centre hospitalo-universitaire. Résultats préliminaires chez 399 patients. Annales de Dermatologie et de Vénéréologie. 142(12). S485–S485. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact